Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Pinotti

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Thrombosis Research|November 3, 2009
Membrane binding and anticoagulant properties of protein S natural variantsMarcello Baroni, Giulia Pavani, Diego Marescotti, et al.
International Journal of Molecular Sciences|November 24, 2020
An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective <i>spf</i>/<i>ash</i> Mouse Model of Ornithine Transcarbamylase DeficiencyDario Balestra, Mattia Ferrarese, Silvia Lombardi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 13, 2020
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2AMatteo Campioni, Paulette Legendre, Cécile Loubiere, et al.
Human Molecular Genetics|April 28, 2018
Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse modelIrving Donadon, Mirko Pinotti, Katarzyna Rajkowska, et al.
Thrombosis and Haemostasis|November 13, 2002
Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strengthRama Kudaravalli, Theresa Tidd, Mirko Pinotti, et al.
Molecular Medicine (Cambridge, Mass.)|December 15, 2021
OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spf<sup>ash</sup> mice, and govern susceptibility to RNA-based therapiesClaudia Sacchetto, Laura Peretto, Francisco Baralle, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2022
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanismsMonica Sacco, Stefano Lancellotti, Alessio Branchini, et al.
Haematologica|April 27, 2010
Chronic sleep deprivation markedly reduces coagulation factor VII expressionMirko Pinotti, Cristiano Bertolucci, Elena Frigato, et al.
Nucleic Acids Research|May 26, 2019
Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNAIrving Donadon, Erica Bussani, Federico Riccardi, et al.
Blood|February 7, 2002
Residual factor VII activity and different hemorrhagic phenotypes in CRM(+) factor VII deficiencies (Gly331Ser and Gly283Ser)Mirko Pinotti, Daniela Etro, Debora Bindini, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Thrombosis Research|November 3, 2009
Membrane binding and anticoagulant properties of protein S natural variantsMarcello Baroni, Giulia Pavani, Diego Marescotti, et al.
International Journal of Molecular Sciences|November 24, 2020
An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective <i>spf</i>/<i>ash</i> Mouse Model of Ornithine Transcarbamylase DeficiencyDario Balestra, Mattia Ferrarese, Silvia Lombardi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 13, 2020
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2AMatteo Campioni, Paulette Legendre, Cécile Loubiere, et al.
Human Molecular Genetics|April 28, 2018
Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse modelIrving Donadon, Mirko Pinotti, Katarzyna Rajkowska, et al.
Thrombosis and Haemostasis|November 13, 2002
Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strengthRama Kudaravalli, Theresa Tidd, Mirko Pinotti, et al.
Molecular Medicine (Cambridge, Mass.)|December 15, 2021
OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spf<sup>ash</sup> mice, and govern susceptibility to RNA-based therapiesClaudia Sacchetto, Laura Peretto, Francisco Baralle, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2022
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanismsMonica Sacco, Stefano Lancellotti, Alessio Branchini, et al.
Haematologica|April 27, 2010
Chronic sleep deprivation markedly reduces coagulation factor VII expressionMirko Pinotti, Cristiano Bertolucci, Elena Frigato, et al.
Nucleic Acids Research|May 26, 2019
Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNAIrving Donadon, Erica Bussani, Federico Riccardi, et al.
Blood|February 7, 2002
Residual factor VII activity and different hemorrhagic phenotypes in CRM(+) factor VII deficiencies (Gly331Ser and Gly283Ser)Mirko Pinotti, Daniela Etro, Debora Bindini, et al.
Pageof 10